Home LiteratureArticle Details
PMID: 2386199 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells.

The American journal of pathology ·Vol. 137 ·No. 2 ·1990-08-00 ·Pages 313-30

Snow AD, Bolender RP, Wight TN, Clowes AW

Abstract

Heparin and related molecules influence vascular wall structure by their ability to inhibit smooth muscle cell (smc) proliferation and migration. However, little is known as to whether heparin has an effect on the extracellular matrix. In the present study, the effect of heparin on the content and regional distribution of elastin, collagen, and proteoglycans (PGs) in blood vessels following experimental injury was determined. Two groups of rats were subjected to left common carotid balloon injury and were infused with either 0.9% saline or heparin in a saline solution, for 2 weeks. Using a new morphometric method of analysis, the authors determined changes in volumes of elastin, collagen, and PGs contained within an 'extracellular matrix domain (ECM domain),' the average envelope of connective tissue surrounding each smc. Heparin treatment inhibited intimal thickening and decreased the elastin content in the ECM domain in the upper and lower arterial intima. Collagen also was found to be significantly decreased 5.0-fold and 7.6-fold in the ECM domains of upper and lower intima, respectively, of heparin-treated animals. The decrease in both elastin and collagen was balanced by a significant increase in amorphous and filamentous electron-dense material. Heparin also caused a significant 1.8-fold and 1.9-fold increase in the PG content in the ECM domain in the upper and lower intima, respectively. Immunohistochemical analysis, using antibodies to elastin and PG subclasses, supported the morphometric observations. This study has shown that heparin administered in vivo can alter the accumulation and distribution of each of the major vascular ECM components in a specific and differential manner.

MeSH Terms
Animals Arteries/cytology,injuries,metabolism Cell Count Collagen/metabolism Elastin/metabolism Extracellular Matrix/drug effects,metabolism,ultrastructure Heparin/physiology Immunohistochemistry Male Microscopy, Electron Muscle, Smooth, Vascular/cytology,drug effects,metabolism Proteoglycans/metabolism Rats Rats, Inbred Strains
Chemicals
Proteoglycans Heparin Collagen Elastin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Snow A D
Department of Pathology, University of Washington, Seattle 98195.
Bolender R P
Wight T N
Clowes A W
References (66)
66 references, click to expand
  1. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels.
    Lab Invest. 1986 Mar;54(3):295-303 PMID: 3512908
  2. Nerve terminal anchorage protein 1 (TAP-1) is a chondroitin sulfate proteoglycan: biochemical and electron microscopic characterization.
    J Cell Biol. 1987 Dec;105(6 Pt 2):3075-86 PMID: 3693407
  3. Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis.
    Lab Invest. 1982 Aug;47(2):124-38 PMID: 7109538
  4. Isolation of a heparan sulfate-containing proteoglycan from basement membrane.
    Proc Natl Acad Sci U S A. 1980 Aug;77(8):4494-8 PMID: 6449008
  5. Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen.
    J Cell Biol. 1985 Feb;100(2):613-9 PMID: 3968183
  6. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.
    Circ Res. 1980 May;46(5):625-34 PMID: 7363412
  7. Ultrastructural localization of proteoglycans in tissue using cuprolinic blue according to the critical electrolyte concentration method: comparison with biochemical data from the literature.
    Histochem J. 1987 Sep;19(9):520-6 PMID: 3440762
  8. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
    J Cell Physiol. 1986 Apr;127(1):1-7 PMID: 2420809
  9. Proteoglycan-collagen interactions in intervertebral disc. A chondroitin sulphate proteoglycan associates with collagen fibrils in rabbit annulus fibrosus at the d-e bands.
    Biosci Rep. 1986 Oct;6(10):879-88 PMID: 3103706
  10. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
    Blood. 1987 Aug;70(2):551-7 PMID: 2955820
  11. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas.
    J Cell Biol. 1987 Sep;105(3):1463-9 PMID: 2888772
  12. Compartmentation and characterization of different proteoglycans in bovine arterial wall.
    J Histochem Cytochem. 1986 Oct;34(10):1293-9 PMID: 2427568
  13. Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension.
    Science. 1987 Jul 24;237(4813):423-6 PMID: 3603030
  14. Heparin modulates the organization of hydrated collagen gels and inhibits gel contraction by fibroblasts.
    J Cell Biol. 1987 Apr;104(4):1097-103 PMID: 3558481
  15. Modulation of types I and III procollagen synthesis at various stages of arterial smooth muscle cell growth in vitro.
    Exp Cell Res. 1984 Jul;153(1):16-24 PMID: 6734737
  16. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.
    J Biol Chem. 1982 Oct 10;257(19):11256-60 PMID: 7118883
  17. Structural determinants of heparin's growth inhibitory activity. Interdependence of oligosaccharide size and charge.
    J Biol Chem. 1989 Jan 25;264(3):1534-42 PMID: 2912971
  18. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization.
    Am J Pathol. 1989 Dec;135(6):1073-88 PMID: 2596571
  19. Effect of heparin on synthesis of short chain collagen by chondrocytes and smooth muscle cells.
    J Cell Biol. 1987 Aug;105(2):1007-12 PMID: 3114266
  20. Biosynthesis of proteodermatan sulfate in cultured human fibroblasts.
    J Biol Chem. 1984 Nov 25;259(22):14144-50 PMID: 6438093
  21. Inhibition by heparin of the oxidation of lysine in collagen by lysyl oxidase.
    Biochemistry. 1988 Apr 19;27(8):2811-5 PMID: 2900022
  22. Heparin modulates human intestinal smooth muscle cell proliferation, protein synthesis, and lattice contraction.
    Gastroenterology. 1987 Oct;93(4):801-9 PMID: 3623023
  23. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
    J Cell Biol. 1981 Aug;90(2):372-9 PMID: 7287812
  24. What controls smooth muscle phenotype?
    Atherosclerosis. 1981 Nov-Dec;40(3-4):347-57 PMID: 7332614
  25. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions.
    Histochemie. 1965 Oct 1;5(3):221-33 PMID: 4223499
  26. Elastin fiber-associated glycosaminoglycans in beta-aminopropionitrile-induced lathyrism.
    Exp Mol Pathol. 1984 Apr;40(2):235-45 PMID: 6705893
  27. Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin.
    Exp Cell Res. 1986 May;164(1):154-62 PMID: 3956591
  28. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration.
    Circ Res. 1986 Jun;58(6):839-45 PMID: 3719930
  29. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Int J Cancer. 1985 Apr 15;35(4):483-91 PMID: 3157649
  30. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.
    Circ Res. 1980 Oct;47(4):578-83 PMID: 6157501
  31. OSTEOPOROSIS, FRACTURES, AND HEPARIN THERAPY.
    JAMA. 1965 Jul 12;193:152 PMID: 14304362
  32. Increased activity of chondroitin sulfate-synthesizing enzymes during proliferation of arterial smooth muscle cells.
    Exp Cell Res. 1986 Dec;167(2):484-94 PMID: 3095130
  33. Mechanisms of stenosis after arterial injury.
    Lab Invest. 1983 Aug;49(2):208-15 PMID: 6876748
  34. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Biochemistry. 1986 Sep 9;25(18):5322-8 PMID: 3768351
  35. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells.
    J Cell Biol. 1985 Apr;100(4):1041-9 PMID: 3156864
  36. Correlation of morphometry and stereology with biochemical analysis of cell fractions.
    Int Rev Cytol. 1978;55:247-89 PMID: 389864
  37. Collagens in atherosclerosis.
    Coll Relat Res. 1985 Jan;5(1):65-97 PMID: 3884248
  38. Immunology of elastin.
    Methods Enzymol. 1987;144:246-59 PMID: 3306284
  39. Proteoglycans and vascular cell proliferation.
    Am Rev Respir Dis. 1989 Oct;140(4):1132-5 PMID: 2508521
  40. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5287-91 PMID: 3474655
  41. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Am J Pathol. 1988 Dec;133(3):456-63 PMID: 2974240
  42. The plasma proteases, thrombin and plasmin, degrade the proteoglycan of rabbit aorta segments in vitro: an integrated ultrastructural and biochemical study.
    Clin Invest Med. 1988 Apr;11(2):139-50 PMID: 2969314
  43. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
    N Engl J Med. 1986 Dec 25;315(26):1650-9 PMID: 3537791
  44. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.
    J Cell Physiol. 1984 Mar;118(3):253-6 PMID: 6699099
  45. Collagen synthesis by human intestinal smooth muscle cells in culture.
    Gastroenterology. 1987 Feb;92(2):400-5 PMID: 3792777
  46. Influence of heparin fragments on the biological activities of elastase(s) and alpha 1 proteinase inhibitor.
    Biochem Pharmacol. 1988 Nov 15;37(22):4257-61 PMID: 2848523
  47. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells.
    J Cell Biol. 1985 Sep;101(3):1059-70 PMID: 4030891
  48. Suppression by heparin of smooth muscle cell proliferation in injured arteries.
    Nature. 1977 Feb 17;265(5595):625-6 PMID: 859561
  49. Mapping of proteoglycans in human arterial tissue.
    Eur J Cell Biol. 1987 Dec;45(1):72-9 PMID: 2450750
  50. "Critical electrolyte concentration" method in histochemistry.
    J Med Lab Technol. 1969 Apr;26(2):124-30 PMID: 4182120
  51. The influence of heparin on the wound healing response to collagen implants in vivo.
    Coll Relat Res. 1988 Jan;8(1):83-100 PMID: 3126022
  52. Proliferation-dependent changes of proteoglycan metabolism in arterial smooth muscle cells.
    Biol Chem Hoppe Seyler. 1987 Mar;368(3):277-84 PMID: 3109451
  53. Inhibition of leucocyte elastase by heparin and its derivatives.
    Biochem J. 1988 Jun 1;252(2):515-9 PMID: 3415672
  54. Mouse bone collagenase. The effect of heparin on the amount of enzyme released in tissue culture and on the activity of the enzyme.
    Calcif Tissue Res. 1973;12(3):247-58 PMID: 4355823
  55. Collagen--proteoglycan interactions. Localization of proteoglycans in tendon by electron microscopy.
    Biochem J. 1980 Jun 1;187(3):887-91 PMID: 7188429
  56. The effects of heparin on the physicochemical properties of reconstituted collagen.
    Coll Relat Res. 1988 Jan;8(1):65-82 PMID: 3126021
  57. Methods for decreasing the statistical variance of stereological estimates.
    Anat Rec. 1983 Sep;207(1):89-106 PMID: 6356990
  58. Regulation of smooth muscle proliferative phenotype by heparinoid--matrix interactions.
    Trends Pharmacol Sci. 1988 Mar;9(3):94-8 PMID: 3072740
  59. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.
    Lab Invest. 1985 Jun;52(6):611-6 PMID: 4040189
  60. Increased elastin mRNA levels associated with surgically induced intimal injury.
    Connect Tissue Res. 1988;18(2):65-78 PMID: 3203520
  61. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates.
    J Biol Chem. 1968 Apr 10;243(7):1536-42 PMID: 4231029
  62. Histochemistry of Alcian blue. 3. The molecular biological basis of staining by Alcian blue 8GX and analogous phthalocyanins.
    Histochemie. 1972;32(3):191-212 PMID: 4117063
  63. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Science. 1987 Aug 14;237(4816):777-9 PMID: 3649921
  64. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit.
    Lab Invest. 1983 Nov;49(5):569-75 PMID: 6632774
  65. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.
    Lab Invest. 1983 Sep;49(3):327-33 PMID: 6887785
  66. Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells.
    Biochem Biophys Res Commun. 1989 Aug 30;163(1):84-92 PMID: 2775295
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1990-08-00
Pages
313-30
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1877596
Subset
IM
Grants
NHLBI NIH HHS · HL 18645 · United States
NHLBI NIH HHS · HL 27769 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]